About the Company
PTC Therapeutics is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases. In September 2009, PTC entered into an agreement with Roche for the development of orally bioavailable small molecules for central nervous system diseases. PTC acquired the Bio-e platform in 2019.
Exchange
Nasdaq
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $PTCT News
Industry Analysts Just Made A Captivating Upgrade To Their PTC Therapeutics, Inc. (NASDAQ:PTCT) Revenue Forecasts
PTC Therapeutics, Inc. (NASDAQ:PTCT) shareholders will have a reason to smile today, with the analysts making substantial ...
PTC Therapeutics: A Balanced Hold Rating Amid Regulatory Challenges and Upcoming Milestones
PTC Therapeutics (PTCT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Jeffrey ...
PTC Therapeutics, Inc. (PTCT) Q1 2024 Earnings Call Transcript
Please go ahead. Good afternoon and thank you for joining us today to discuss PTC Therapeutics first quarter 2024 corporate update and financial results. I'm joined today by our Chief Executive ...
PTC Therapeutics: Q1 Earnings Snapshot
SOUTH PLAINFIELD, N.J. (AP) — SOUTH PLAINFIELD, N.J. (AP) — PTC Therapeutics Inc. (PTCT) on Thursday reported a loss of $91.6 million in its first quarter. The South Plainfield, New Jersey-based ...
Sell Rating on PTC Therapeutics Amid Sustainability Concerns and Market Uncertainties
Analyst Paul Choi of Goldman Sachs maintained a Sell rating on PTC Therapeutics (PTCT – Research Report), retaining the price target of ...
PTC Therapeutics Provides Corporate Update and Reports First Quarter 2024 Financial Results
This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. All statements contained in this release, other than statements of ...
PTC Therapeutics Inc PTCT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
PTC Therapeutics Inc (PTCT) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth ...
Unveiling robust financial performance and strategic expansions in Q1 2024, PTC Therapeutics Inc (PTCT) sets a promising trajectory.
Q1 2024 PTC Therapeutics Inc Earnings Call
Good day, and thank you for standing by, and welcome to PTC's first-quarter 2024 financial results conference call. (Operator Instructions) Please be advised that today's conference is being recorded.
PTC Therapeutics Inc PTCT
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
PTC Therapeutics Inc
What's the difference between mutual funds and stocks? For starters, they suit different investing styles.
Loading the latest forecasts...